Assessing the impact of mRNA vaccination in chronic inflammatory murine model

Bibliographic Details
Title: Assessing the impact of mRNA vaccination in chronic inflammatory murine model
Authors: Seonghyun Lee, Jisun Lee, Sun-Hee Cho, Gahyun Roh, Hyo-Jung Park, You-Jeung Lee, Ha-Eun Jeon, Yu-Sun Lee, Seo-Hyeon Bae, Sue Bean Youn, Youngran Cho, Ayoung Oh, Dahyeon Ha, Soo-Yeon Lee, Eun-Jin Choi, Seongje Cho, Sowon Lee, Do-Hyung Kim, Min-Ho Kang, Mee-Sup Yoon, Byung-Kwan Lim, Jae-Hwan Nam
Source: npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)
Publisher Information: Nature Portfolio, 2024.
Publication Year: 2024
Collection: LCC:Immunologic diseases. Allergy
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract The implications of administration of mRNA vaccines to individuals with chronic inflammatory diseases, including myocarditis, rheumatoid arthritis (RA), and inflammatory bowel disease (IBD), are unclear. We investigated mRNA vaccine effects in a chronic inflammation mouse model implanted with an LPS pump, focusing on toxicity and immunogenicity. Under chronic inflammation, mRNA vaccines exacerbated cardiac damage and myocarditis, inducing mild heart inflammation with heightened pro-inflammatory cytokine production and inflammatory cell infiltration in the heart. Concurrently, significant muscle damage occurred, with disturbances in mitochondrial fusion and fission factors signaling impaired muscle repair. However, chronic inflammation did not adversely affect muscles at the vaccination site or humoral immune responses; nevertheless, it partially reduced the cell-mediated immune response, particularly T-cell activation. These findings underscore the importance of addressing mRNA vaccine toxicity and immunogenicity in the context of chronic inflammation, ensuring their safe and effective utilization, particularly among vulnerable populations with immune-mediated inflammatory diseases.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2059-0105
Relation: https://doaj.org/toc/2059-0105
DOI: 10.1038/s41541-024-00825-z
Access URL: https://doaj.org/article/9c99544e79be48e9a215db542194e81e
Accession Number: edsdoj.9c99544e79be48e9a215db542194e81e
Database: Directory of Open Access Journals
More Details
ISSN:20590105
DOI:10.1038/s41541-024-00825-z
Published in:npj Vaccines
Language:English